Related Experiment Videos

Viewing apoptosis through a 'TUNEL'

J A Walker1, P Quirke

  • 1Department of Pathology, Algernon Firth Building, University of Leeds, Leeds LS2 9JT, UK.

The Journal of Pathology
|October 24, 2001
PubMed

Insights

Quantifying apoptotic bodies is crucial for understanding cancer development and treatment. This study reviews techniques like TUNEL, M30, and caspase 3 to accurately measure these cell death remnants.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Apoptosis plays a critical role in both cancer development (carcinogenesis) and its treatment.
  • The formation of apoptotic bodies is the final outcome of the apoptotic pathway.
  • Accurate quantification of apoptotic bodies is essential for studying the apoptosis process.

Discussion:

  • The Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay is a common method for detecting DNA fragmentation during apoptosis.
  • Potential drawbacks of the TUNEL assay include its sensitivity to DNA breaks not related to apoptosis and potential for false positives.
  • Newer antibody-based techniques, such as those targeting M30 (a marker of activated caspase-6) and caspase 3 (a key executioner caspase), offer more specific detection of apoptotic events.

Key Insights:

  • Accurate quantification of apoptotic bodies is vital for cancer research and therapy assessment.
  • While TUNEL is widely used, its limitations necessitate exploration of alternative methods.
  • Antibody techniques like M30 and caspase 3 provide more precise markers for apoptotic events.

Outlook:

  • Further validation and standardization of antibody-based assays are needed.
  • Integration of these advanced techniques can improve our understanding of apoptosis in cancer.
  • Improved quantification methods will aid in developing more effective cancer therapies.

Related Concept Videos